Nykredit A S purchased a new stake in shares of Moderna, Inc. (NASDAQ: MRNA) in the second quarter, according to its most recent filing with the Securities and Exchange Commission. The firm purchased 13,042 shares of the company's stock, valued at approximately $913,000. Other hedge funds have also recently made changes to their
Read on defenseworld.net